Latest Coverage of COVID-19 in NEJM Journal Watch

We present new summaries, commentary, and news on the pandemic.

Dear readers,

NEJM Journal Watch recently covered COVID-19–related topics including therapeutic anticoagulation; vaccine responses in immunocompromised patients; symptom burden, mental health, and vaccine side effects in children and teens; saliva testing; COVID-19 outcomes in patients with sickle cell disease; Guillain-Barré syndrome; MIS-C; rapid antigen tests; inhaled steroids; life expectancy; and breakthrough infections.

This information appears on the NEJM Journal Watch COVID-19 page (https://www.jwatch.org/covid-19) and on the New England Journal of Medicine coronavirus site (https://www.nejm.org/coronavirus).

As always, we continue to provide our regular coverage of other important infectious diseases research.

Author

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

Latest Coverage of COVID-19 in NEJM Journal Watch

Topics

Author